|
|
Vol. 25.26 – 19 August, 2024
|
|
|
|
|
|
|
|
The authors used genome-wide screening in Fanconi anemia patient lymphoblastic cell lines to uncover suppressors of CRISPR–Cas9-mediated homology-directed repair. [Nature Biotechnology]
|
|
|
|
|
|
PUBLICATIONSListed by the impact factor of the journal
|
|
|
|
|
|
In CT26 tumor-bearing mouse model, FMRP degradation within tumors substantially promoted the infiltration of lymphocytes and CD8 T cells and reduced the proportion of Treg cells, reshaping the proinflammatory tumor microenvironment and accordingly transforming cold tumor into hot tumor.
[Angewandte Chemie-International Edition]
|
|
|
|
|
|
Scientists presented DARPin-targeted AAVs (DART-AAVs) displaying DARPins specific for human and murine CD8. Insertion of DARPins into the GH2/GH3 loop of the capsid protein 1 of AAV2 and AAV6 resulted in high selectivity for CD8-positive T cells with unimpaired gene delivery activity.
[Molecular Therapy]
|
|
|
|
|
|
Two I-SPY2 cohorts and one West China Hospital cohort of patients treated with neoadjuvant chemoimmunotherapy were included. Machine learning algorithms were used to identify key genes. Principal component analysis was used to calculate the ImPredict score. [Journal For Immunotherapy of Cancer]
|
|
|
|
|
|
Researchers reported a novel nanomedicine that converts the hepatic immune microenvironment to a “hot” phenotype by targeting hepatic macrophage-centric T cell elimination. [Journal of Controlled Release]
|
|
|
|
|
|
Scientists present the first transactivator-free anti-CD19 CAR-T cells able to control IL-18 expression under ultra-low doses of doxycycline and without altering cellular fitness.
[Molecular Therapy – Nucleic Acids]
|
|
|
|
|
|
Investigators developed lentiviral vector (LVV) packaging and producer cell lines, which reduced or eliminated the need for plasmid transfection during LVV manufacture. To develop a packaging cell line, lentiviral packaging genes were stably integrated by random integration of linearised plasmid DNA.
[Molecular Therapy-Methods & Clinical Development]
|
|
|
|
|
|
Researchers administered mouse adipose tissue-derived mesenchymal stem cells (mASCs) labeled with quantum dots to a mouse model of bleomycin-induced pulmonary fibrosis in an effort to clarify the relationship between in vivo dynamics and therapeutic efficacy. [Scientific Reports]
|
|
|
|
|
|
Investigators generated a series of adeno-associated viruses (AAV) libraries containing variations at three residues (Y446, N470, and W503) of the galactose-binding pocket of the AAV9 VP1 protein. [Human Gene Therapy]
|
|
|
|
|
|
|
|
To fully unleash the potential of cell therapy in regenerative medicine, it is beneficial to adopt, adapt, or develop better tools to produce high-quality cell-based products through various biofabrication techniques.
[Science]
|
|
|
|
|
|
The authors discuss the mechanisms by which CAR-T cells target autoimmune conditions, summarize current preclinical models, and highlight ongoing clinical trials, including CAR-T therapy design, clinical outcomes, and challenges.
[Trends In Pharmacological Sciences]
|
|
|
|
|
|
Scientists comprehensively examine recent developments and challenges in stem cell transplantation, exploring the identification and isolation of various stem cell types, including embryonic, induced pluripotent, and adult stem cells derived from multiple sources. [Heliyon]
|
|
|
|
|
|
|
|
Bristol Myers Squibb announced that the European Medicines Agency has validated its Type II variation application to expand the indication for Breyanzi, a CD19-directed CAR T cell therapy, to include the treatment of adult patients with relapsed or refractory follicular lymphoma who have received two or more prior lines of systemic therapy. [Bristol Myers Squibb]
|
|
|
|
|
|
Turnstone Biologics is narrowing the focus of Phase I trials of its lead tumor-infiltrating lymphocyte therapy, with cutaneous melanoma and breast cancer no longer in the mix. [Fierce Biotech]
|
|
|
|
|
|
|
|
September 21 – 26, 2024 Dubrovnik, Croatia
|
|
|
|
|
|
|
|
|
|
|
Lyell – Seattle, Washington, United States
|
|
|
|
|
|
|
Ludwig Boltzmann Institute for Traumatology – Vienna, Austria
|
|
|
|
|
|
|
AstraZeneca – Boston, Massachusetts, United States
|
|
|
|
|
|
|
Takeda – Boston, Massachusetts, United States
|
|
|
|
|
|
|
The University of Edinburgh – Edinburgh, Scotland, United Kingdom
|
|
|
|
|
|